Neurocrine Bio. (NBIX) PT Lowered to $107 at Wedbush
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $158.35 +0.35%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 28
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 28
Join SI Premium – FREE
Wedbush analyst Laura Chico lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $107.00 (from $112.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Neurocrine Bio. (NBIX) PT Raised to $253 at Citi
- Intel (INTC) PT Lowered to $92 at Mizuho
- CLSA Downgrades Jiangsu Yanghe Brewery (002304:CH) to Hold (3)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
